Summary of Significant Accounting Policies (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2018	Dec. 31, 2017
Cash, FDIC insured amount	$ 250,000
Operating loss carryforwards		$ 258,000
Income tax percentage	21.00%		34.00%
Income tax benefit		$ 0	$ 0
Deferred tax assets and liabilities			$ 14,500,000
Common Stock [Member] | Stock Options and Warrants [Member]
Potentially dilutive securities	14,811,333
Convertible Series A Preferred Stock [Member]
Potentially dilutive securities	602
Convertible Series A Preferred Stock [Member] | Sabby Master Healthcare Ltd [Member]
Potentially dilutive securities	382
Convertible Series A Preferred Stock [Member] | Nostrum Pharmaceuticals, LLC [Member]
Potentially dilutive securities	220
Convertible Series A Preferred Stock [Member] | Common Stock [Member]
Number of shares converted during period	53,274,336
Series B Convertible Preferred Stock [Member]
Potentially dilutive securities	1,700,000
Series B Convertible Preferred Stock [Member] | Common Stock [Member]
Number of shares converted during period	150,442,478
Federal [Member]
Operating loss carryforwards	$ 91,400,000
Operating loss carryforwards expiration, description	The net operating losses begin to expire in 2023 for federal income purposes
Federal [Member] | Research and Development Credit [Member]
Income tax credits	$ 1,800,000
Income tax credits, expiration date	Dec. 31, 2035
State [Member]
Operating loss carryforwards	$ 52,500,000
Operating loss carryforwards expiration, description	In 2028 for state income tax purposes.
State [Member] | Research and Development Credit [Member]
Income tax credits	$ 1,900,000
Minimum [Member]
Property and equipment, estimated useful life	3 years
Maximum [Member]
Property and equipment, estimated useful life	5 years